LionBird Ventures is a Tel Aviv-based venture capital firm founded in 2012 that focuses on pre-seed and seed investments in digital health and medical technologies. It has a strong emphasis on the Israeli startup ecosystem and is particularly active at the earliest stages of company building. Its model is oriented around first-check capital and operational support.

The firm has demonstrated neurotech interest through investments such as Phantom Neuro, which sits at the intersection of prosthetics, BCI, and medical devices. LionBird’s broader healthcare focus means it is most relevant to companies blending hardware, software, and clinical use cases rather than highly capital-intensive later-stage therapeutics. It plays an important role in helping early companies move from research and concept toward commercial formation.

LionBird primarily invests in Israel and the United States. For neurotech founders, it is especially relevant if the company is emerging from the Israeli ecosystem or has a digital health and medical device orientation. It stands out as an early-stage, regionally strong investor for neurotechnology companies with practical clinical applications.